Clinical Trials Logo

IPMN, Pancreatic clinical trials

View clinical trials related to IPMN, Pancreatic.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06276764 Not yet recruiting - Pancreas Cancer Clinical Trials

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Start date: June 15, 2024
Phase:
Study type: Observational [Patient Registry]

In this study, LINFU® will be evaluated in patients who have been identified with IPMN to determine if it can be used to help identify early, pancreatic ductal adenocarcinoma and its noninvasive precursor lesions (dysplasia). The study will also help determine if LINFU® results in earlier intervention, treatment and improvement in patient outcomes.

NCT ID: NCT05593393 Not yet recruiting - IPMN, Pancreatic Clinical Trials

A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm

Start date: December 2022
Phase:
Study type: Observational

Study objective: To establish a long-term follow-up cohort of patients with IPMN, study the follow-up, clinical outcomes and prognostic factors of patients with IPMN, and provide a basis for clinical decisions and guidelines. Study design: This is a real world, multicenter, prospective, observational cohort study